Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pancreatic Enzymes and Bile Acids in Malnourished Children
NCT04542473Phase 3Unknown
- Sponsor
- University of Oxford
- Start
- Jul 2021
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands, Replacement Enzymes
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial of pancrelipase and ursodeoxycholic acid in severe acute malnutrition (SAM) (4 arms), sponsored by University of Oxford. Primary endpoint: Mortality at 60 days. Status: unknown.
02
Drugs
pancrelipaseursodeoxycholic acid
03
Conditions
severe acute malnutrition (SAM)
Beyond the preview
Go deeper on NCT04542473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04542473.